• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有症状的新冠病毒感染康复者的心血管后遗症

Cardiovascular sequelae in symptomatic SARS-CoV-2 infection survivors.

作者信息

Skonieczny Grzegorz, Skowrońska Marta, Dolacińska Agnieszka, Ratajczak Beata, Sulik Patrycja, Doroba Oliwia, Kotula Alicja, Błażejowska Ewelina, Staniszewska Izabela, Domaszk Olaf, Pruszczyk Piotr

机构信息

Cardiology Department and Intensive Cardiac Unit, Provincial Polyclinical Hospital, Torun, Poland.

Department of Internal Medicine & Cardiology, Medical University of Warsaw, Warsaw, Poland.

出版信息

Cardiol J. 2025;32(1):1-8. doi: 10.5603/cj.99538. Epub 2024 Nov 7.

DOI:10.5603/cj.99538
PMID:39506902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11870002/
Abstract

BACKGROUND

SARS-CoV-2 infection may lead to myocardial and endothelial damage. The present study sought to characterize the cardiovascular sequel in a large group of consecutive patients admitted for out-patient cardiovascular follow-up after a symptomatic COVID-19 infection.

METHODS

The aims of this study were as follows: to evaluate the presence of post-covid cardiovascular symptoms in an unselected population of outpatients referred to a post-COVID outpatient cardiology clinic and to characterize the long-term abnormalities associated with a more severe COVID-19 infection clinical course. A total of 914 patients were included in this single-center, observational, cross-sectional study, of which 163 were hospitalized and 149 required mechanical ventilation for COVID-19 pneumonia. Patients were analyzed at follow-up according to the care setting during the initial presentation.

RESULTS

The median time to follow-up was 126 days. At that time, only 3.5% of patients reported no persistent dyspnea, chest pain, or fatigue on exertion. In a follow-up echocardiographic assessment, patients who required hospitalization showed slight alterations in the pulmonary acceleration time and the tricuspid regurgitation pressure gradient, as well as reduced exercise tolerance during treadmill exercise testing when compared to patients with a benign clinical course. 24-hour Holter EKG monitoring or 24-hour blood pressure monitoring did not identify significant differences between the analyzed subgroups.

CONCLUSIONS

The current study reports on an association between COVID-19 severity and the presence of cardiovascular alterations at follow-up. A simple diagnostic protocol, comprising an exercise treadmill test and transthoracic echocardiography is useful in identifying patients who may benefit from regular, structured cardiovascular medical care.

摘要

背景

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染可能导致心肌和内皮损伤。本研究旨在对一大组有症状的新型冠状病毒肺炎(COVID-19)感染后因门诊心血管随访而入院的连续患者的心血管后遗症进行特征描述。

方法

本研究的目的如下:评估转诊至COVID-19门诊心脏病诊所的未选择门诊患者群体中COVID-19后心血管症状的存在情况,并对与更严重的COVID-19感染临床病程相关的长期异常进行特征描述。本单中心、观察性横断面研究共纳入914例患者,其中163例曾住院治疗,149例因COVID-19肺炎需要机械通气。根据初次就诊时的护理情况对患者进行随访分析。

结果

随访的中位时间为126天。那时,只有3.5%的患者报告在运动时没有持续的呼吸困难、胸痛或疲劳。在随访超声心动图评估中,与临床病程较轻的患者相比,需要住院治疗的患者在肺动脉加速时间和三尖瓣反流压力梯度方面有轻微改变,并且在平板运动试验中的运动耐量降低。24小时动态心电图监测或24小时血压监测未发现分析的亚组之间存在显著差异。

结论

本研究报告了COVID-19严重程度与随访时心血管改变之间的关联。一个简单的诊断方案,包括平板运动试验和经胸超声心动图,有助于识别可能从定期、结构化心血管医疗护理中获益的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/11870002/06b99b507ac3/cardj-32-1-1f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/11870002/c411f44fe154/cardj-32-1-1f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/11870002/06b99b507ac3/cardj-32-1-1f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/11870002/c411f44fe154/cardj-32-1-1f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/11870002/06b99b507ac3/cardj-32-1-1f2.jpg

相似文献

1
Cardiovascular sequelae in symptomatic SARS-CoV-2 infection survivors.有症状的新冠病毒感染康复者的心血管后遗症
Cardiol J. 2025;32(1):1-8. doi: 10.5603/cj.99538. Epub 2024 Nov 7.
2
COVID-19 in Female and Male Athletes: Symptoms, Clinical Findings, Outcome, and Prolonged Exercise Intolerance-A Prospective, Observational, Multicenter Cohort Study (CoSmo-S).新型冠状病毒肺炎在女性和男性运动员中的表现:症状、临床发现、结局和运动耐量持续受限——一项前瞻性、观察性、多中心队列研究(CoSmo-S)。
Sports Med. 2024 Apr;54(4):1033-1049. doi: 10.1007/s40279-023-01976-0. Epub 2024 Jan 11.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.SARS-CoV-2 生物库的纵向研究,用于 COVID-19 幸存者,包括有无急性后期后遗症。
BMC Infect Dis. 2021 Jul 13;21(1):677. doi: 10.1186/s12879-021-06359-2.
5
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.新冠病毒感染后急性后遗症/新冠后综合征成年患者在急性感染后第二年的持续症状及临床发现:一项基于人群的巢式病例对照研究
PLoS Med. 2025 Jan 23;22(1):e1004511. doi: 10.1371/journal.pmed.1004511. eCollection 2025 Jan.
6
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
7
Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort.严重 COVID-19 肺部感染后运动能力受损因素的鉴定:前瞻性 COVulnerability 队列的 3 个月随访。
Respir Res. 2022 Mar 22;23(1):68. doi: 10.1186/s12931-022-01977-z.
8
Medium-Term Disability and Long-Term Functional Impairment Persistence in Survivors of Severe COVID-19 ARDS: Clinical and Physiological Insights.中重度残疾和长期功能障碍在重症 COVID-19 ARDS 幸存者中的持续存在:临床和生理学见解。
Arch Bronconeumol. 2024 Oct;60(10):619-626. doi: 10.1016/j.arbres.2024.05.021. Epub 2024 May 28.
9
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.COVID-19 住院幸存者 2 年后的健康结局:一项纵向队列研究。
Lancet Respir Med. 2022 Sep;10(9):863-876. doi: 10.1016/S2213-2600(22)00126-6. Epub 2022 May 11.
10
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort.新冠肺炎危重症幸存者的肺功能和影像学特征:一项为期 3 个月的前瞻性队列研究。
Chest. 2021 Jul;160(1):187-198. doi: 10.1016/j.chest.2021.02.062. Epub 2021 Mar 4.

本文引用的文献

1
Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2.COVID-19 后急性综合征的心血管症状表型。
Int J Cardiol. 2022 Nov 1;366:35-41. doi: 10.1016/j.ijcard.2022.07.018. Epub 2022 Jul 13.
2
Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review.急性新冠病毒感染后综合征的康复干预措施:系统评价。
Int J Environ Res Public Health. 2022 Apr 24;19(9):5185. doi: 10.3390/ijerph19095185.
3
Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician.
新型冠状病毒肺炎的长期心血管影响:与心血管临床医生相关的新兴数据。
Curr Atheroscler Rep. 2022 Jul;24(7):563-570. doi: 10.1007/s11883-022-01032-8. Epub 2022 May 4.
4
Imaging Findings of COVID-19-Related Cardiovascular Complications.COVID-19 相关心血管并发症的影像学表现。
Card Electrophysiol Clin. 2022 Mar;14(1):79-93. doi: 10.1016/j.ccep.2021.10.008. Epub 2021 Oct 30.
5
Long-term cardiovascular outcomes of COVID-19.COVID-19 长期心血管后果。
Nat Med. 2022 Mar;28(3):583-590. doi: 10.1038/s41591-022-01689-3. Epub 2022 Feb 7.
6
Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes.新型冠状病毒感染住院期间心肌损伤与长期预后的关系。
J Am Heart Assoc. 2022 Jan 4;11(1):e022010. doi: 10.1161/JAHA.121.022010. Epub 2021 Dec 31.
7
Long-term complications of COVID-19.COVID-19 的长期并发症。
Am J Physiol Cell Physiol. 2022 Jan 1;322(1):C1-C11. doi: 10.1152/ajpcell.00375.2021. Epub 2021 Nov 24.
8
Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.COVID-19 大流行后期的普通心脏病学。ESC 心脏病学实践理事会立场文件。
ESC Heart Fail. 2021 Oct;8(5):3483-3494. doi: 10.1002/ehf2.13466. Epub 2021 Jun 25.
9
Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis.SARS-CoV-2 感染(COVID-19)的心血管并发症:系统评价和荟萃分析。
Rev Cardiovasc Med. 2021 Mar 30;22(1):159-165. doi: 10.31083/j.rcm.2021.01.238.
10
Post-acute COVID-19 syndrome.新冠病毒感染后长期综合征。
Nat Med. 2021 Apr;27(4):601-615. doi: 10.1038/s41591-021-01283-z. Epub 2021 Mar 22.